Tweets
Henningson et al. IV methylpred in GCA. No better visual acuity, higher cumulative GC at 3 months, higher diabetes. Interesting! I find it so hard not to give, in case the contralateral eye gets it, but no evidence for this @rheumnow #ACR22 Abstr#0459 https://t.co/yMcw2HGQUx https://t.co/tNKUgYNTdG
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Morning stiffness has the highest correlate to disease activity in pregnant AS patients, as demonstrated in Abs 0374. I will indeed be focusing on this much more for my patients. #ACR22 #ACRbest @RheumNow https://t.co/9bmlQtGsLH https://t.co/qrxebQ6Ow1
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
RheumNow’s expanded coverage of the #ACR22 Annual meeting is sponsored in part by Novartis. All content chosen by RheumNow & its Faculty
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Kunishita et al Abatacept in those with RA and prev cancer (or not). Equally effective. No significant difference in 5-year malignancy but those curves look like they are diverging to me! @rheumnow #ACR22 Abstr#0255 https://t.co/1E2SXMGbqD https://t.co/gTvOOnuzo0
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
What do you do if a person with #rheumatoidarthritis was great on 1st JAKi. It was 1st line advanced Rx @RheumNow #ACR22
Janet Pope @Janetbirdope ( View Tweet )
3 years 8 months ago
They're #dopplegangers! #IgG4RD and #GPA both can have similar clinical manifestations, storiform fibrosis and elevated IgG4 levels. Distinguishing factors can be: necrosis, granulomatous inflammation, neutrophilic inflammation, and presence of ANCA #ACR22 @rheumnow https://t.co/6bHibsvcV8
TheDaoIndex @KDAO2011 ( View Tweet )
3 years 8 months ago
DISCOVER-2:
Guselkumab in bionaïve PsA
Work productivity data at 2 yrs
64% employed at BL; 50% work impairment at BL
84% employed at BL continued to work
Amongst unemployed at BL proportion of pts working rose by >=20%
https://t.co/zqmfFvPPMi
Abst #0509 #ACR22 @Rheumnow https://t.co/J9Fhj1qHfV
Aurelie Najm @AurelieRheumo ( View Tweet )
3 years 8 months ago
Migratory oligoarticular arthritis of AAV favors the lower extremities and may herald a flare. – Dr. J Stone #ACR22 @rheumnow https://t.co/VdBaeNyCR3
TheDaoIndex @KDAO2011 ( View Tweet )
3 years 8 months ago
Yamaguchi et al. Effect of concurrent RO62 abs in Jo1+ antisynthetase syndrome. Present in 16%. Associated more muscle involvement 85% vs 59% (p=0.011). Maybe more Raynauds 56% vs 38% (p=0.09)
@rheumnow
#ACR22 Abstr#0162 https://t.co/6XH6qNKkn7 https://t.co/1JQCtCWrw0
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
"Serum complement levels are the Rosetta Stone for understanding lupus activity in pregnancy." Dr. Stone @RheumNow #ACR22 https://t.co/4FbThAZyvq
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
Raynaud's may not be first presenting symptom in SSc with RNA Pol3 antibodies. May be a mimic of early inflammatory arthritis. Implications for steroid use.
@RheumNow #ACR22 #Pearls https://t.co/FO8dtOTn9V
Julian Segan @JulianSegan ( View Tweet )
3 years 8 months ago
How is BASDAI reflecting dis activity in pregnant women w/ AS?
Back pain and fatigue from 2nd sem onwards & BASDAI in 3rd sem = poor sens & spe.
Morning stiffness = highest classification value. https://t.co/pafKqpmZFq
Abstr #0374 #ACR22 @Rheumnow https://t.co/IJY0hm01GW
Aurelie Najm @AurelieRheumo ( View Tweet )
3 years 8 months ago


